Jan Biotech (United States)

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Laurent Peyrin‐Biroulet, Walter Reinisch, Jean–Frédéric Colombel et al. · Gut · 2013 · 493 citations

Medicine, Clinical Sciences, Immunology +17

Change in Erythrocyte Mean Corpuscular Volume During Combination Therapy with Azathioprine and Infliximab Is Associated with Mucosal Healing

Guillaume Bouguen, Charles A. Sninsky, Kezhen L. Tang et al. · Inflammatory Bowel Diseases · 2015 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

CRISPR-Mediated Single Nucleotide Polymorphism Modeling in Rats Reveals Insight Into Reduced Cardiovascular Risk Associated With Mediterranean <i>G6PD</i> Variant

A. Kitagawa, Igor V. Kizub, Christina Jacob et al. · Hypertension · 2020 · 27 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study

Roy Fleischmann, John A. Goldman, Marjatta Leirisalo‐Repo et al. · Current Medical Research and Opinion · 2014 · 14 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17